{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:45:19Z","timestamp":1790858719062,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013136","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000}}],"reference-count":102,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013136.pub2","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T03:02:55Z","timestamp":1658113375000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy"],"prefix":"10.1002","volume":"2022","author":[{"given":"Chris","family":"Eaton","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK"},{"name":"Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences; Cardiff University; Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneith","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences; Royal Hospital for Children and Young People; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Walter","sequence":"additional","affiliation":[{"name":"Muir Maxwell Epilepsy Centre, Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gashirai K","family":"Mbizvo","sequence":"additional","affiliation":[{"name":"The Walton Centre NHS Foundation Trust; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard FM","family":"Chin","sequence":"additional","affiliation":[{"name":"Muir Maxwell Epilepsy Centre, Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0001|cit1","first-page":"28","article-title":"Clinical trial of efficacy evaluation of omega-3 with risperidone on seizures frequency in children with refractory epilepsy and attention-deficit\/hyperactivity disorder","volume":"12","author":"Fallah","year":"2018","journal-title":"Iranian Journal of Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD013136.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yebeh.2010.02.022","article-title":"Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy","volume":"18","author":"Gonzalez-Heydrich","year":"2010","journal-title":"Epilepsy & Behavior"},{"issue":"12","key":"10.1002\/14651858.CD013136.pub2-BIB0003|cit3","first-page":"725","article-title":"OROS methylphenidate for attention-deficit\/hyperactivity disorder plus epilepsy","volume":"31","author":"Gonzalez-Heydrich","year":"2006","journal-title":"P and T (Pharmacy and Therapeutics)"},{"issue":"12","key":"10.1002\/14651858.CD013136.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/epi.13917","article-title":"Methylphenidate, cognition, and epilepsy: a 1-month open-label trial","volume":"58","author":"Adams","year":"2017","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD013136.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02751207","article-title":"Evaluation of BR-16 A (Mentat) in cognitive and behavioural dysfunction of mentally retarded children - a placebo-controlled study","volume":"60","author":"Dave","year":"1993","journal-title":"Indian Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-0035-1557234","article-title":"An open clinical trial of risperidone in children with seizures and hyperactivity","volume":"3","author":"Eapen","year":"2005","journal-title":"Journal of Pediatric Neurology"},{"issue":"9","key":"10.1002\/14651858.CD013136.pub2-BIB0007|cit7","first-page":"1081","article-title":"Methylphenidate in children with seizures and attention-deficit disorder","volume":"143","author":"Feldman","year":"1989","journal-title":"American Journal of Diseases of Children"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/155005949302400106","article-title":"Visual event related potentials after methylphenidate and sodium valproate in children with attention deficit hyperactivity disorder","volume":"24","author":"Frank","year":"1993","journal-title":"Clinical Electroencephalography"},{"issue":"2-3","key":"10.1002\/14651858.CD013136.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000117996","article-title":"l-Tryptophan in hyperactive child syndrome associated with epilepsy: a controlled study","volume":"10","author":"Ghose","year":"1983","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0022-3476(97)70258-0","article-title":"Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? [Republished from Journal of Pediatrics; 1997 Jan;130(1):40-4; PMID: 9003849]","volume":"130","author":"Gross-Tsur","year":"1997","journal-title":"Journal of Pediatrics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD013136.pub2-BIB0011|cit11","first-page":"206","article-title":"The efficacy of methylphenidate in children with epilepsy and ADHD: the role of dosage, epilepsy type and psychiatric comorbidity","volume":"45","author":"Gunning","year":"2004","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD013136.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mds.870110615","article-title":"Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus\/Piracetam Study Group","volume":"11","author":"Ikeda","year":"1996","journal-title":"Movement Disorders"},{"issue":"4-5","key":"10.1002\/14651858.CD013136.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/1545968318765498","article-title":"L-Carnosine in pediatric cognitive disorders","volume":"32","author":"Moorthy","year":"2018","journal-title":"Neurorehabilitation and Neural Repair"},{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/ebmh.11.4.118","article-title":"Transdermal methylphenidate more effective than placebo for treating ADHD","volume":"11","author":"Swanson","year":"2008","journal-title":"Evidence Based Mental Health"},{"issue":"3","key":"10.1002\/14651858.CD013136.pub2-BIB0015|cit15","first-page":"659","article-title":"Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial [Erratum appears in Epilepsy & Behavior, 2006 Nov;9(3):542]","volume":"8","author":"Feltz-Cornelis C","year":"2006","journal-title":"Epilepsy & Behavior"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eplepsyres.2016.08.001","article-title":"Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: the FYDATA study","volume":"126","author":"Villanueva","year":"2016","journal-title":"Epilepsy Research"},{"issue":"7","key":"10.1002\/14651858.CD013136.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1469-8749.2007.00498.x","article-title":"Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine","volume":"49","author":"Wernicke","year":"2007","journal-title":"Developmental Medicine & Child Neurology"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0018|cit18","unstructured":"Efficacy of phosphatidylserine enriched with n-3 PUFA supplementation on ADHD in children with epilepsy clinicaltrials.gov\/ct2\/show\/NCT02348073"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0019|cit19","volume-title":"Manual for the Child Behavior Checklist\/4-18 and 1991 Profile","author":"Achenbach","year":"1991"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1542\/peds.86.2.184","article-title":"Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation","volume":"86","author":"Barkley","year":"1990","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0021|cit21","volume-title":"BNF 73 (British National Formulary)","author":"Joint Formulary Committee","year":"2017"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.biopsych.2017.08.006","article-title":"Familial liability to epilepsy and attention-deficit\/hyperactivity disorder: a nationwide cohort study","volume":"83","author":"Brikell","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD013136.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11910-013-0351-6","article-title":"The diagnosis and treatment of attention deficit hyperactivity disorder in patients with epilepsy","volume":"13","author":"Brown","year":"2013","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"7","key":"10.1002\/14651858.CD013136.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/bph.12052","article-title":"Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?","volume":"168","author":"Cardamone","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0025|cit25","unstructured":"Centers for Disease Prevention and Control Data and Statistics About ADHD www.cdc.gov\/ncbddd\/adhd\/data.html 2017"},{"issue":"8","key":"10.1002\/14651858.CD013136.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.biopsych.2013.10.005","article-title":"Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit\/hyperactivity disorder: evidence from a systematic review and a meta-analysis","volume":"76","author":"Coghill","year":"2014","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0883073812440327","article-title":"Prevalence of epilepsy and attention-deficit hyperactivity disorder (ADHD): a population-based study","volume":"28","author":"Cohen","year":"2013","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0028|cit28","volume-title":"Conners 3rd Edition","author":"Conners","year":"2008"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0029|cit29","unstructured":"Covidence Veritas Health Innovation"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD013136.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"e63859","DOI":"10.1371\/journal.pone.0063859","article-title":"Children with ADHD symptoms have a higher risk for reading, spelling and math difficulties in the GINIplus and LISAplus cohort studies","volume":"8","author":"Czamara","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0973-1229.87261","article-title":"Drug therapy of attention deficit hyperactivity disorder: current trends","volume":"10","author":"De Sousa","year":"2012","journal-title":"Mens Sana Monographs"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0033|cit33","volume-title":"DSM-IV: Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0034|cit34","volume-title":"DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders Text Revision","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0035|cit35","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"DSM-V: Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0036|cit36","volume-title":"ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation","author":"DuPaul","year":"1998"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0037|cit37","unstructured":"Schachter SC Shafer P Sirven J Who gets epilepsy? Available at www.epilepsy.com\/learn\/epilepsy-101\/who-gets-epilepsy 2013"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0038|cit38","unstructured":"EPOC Resources for review authors: data collection form epoc.cochrane.org\/sites\/epoc.cochrane.org\/files\/public\/uploads\/Resources-for-authors2017\/good_practice_data_extraction_form.doc 2017"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0039|cit39","unstructured":"Strattera (atomoxetine HCl) Available at www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/021411s004s012s013s015s021lbl.pdf; 2006"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0040|cit40","unstructured":"Fisher R Epilepsy: a new definition; 2014 Available at: www.epilepsy.com\/article\/2014\/4\/revised-definition-epilepsy"},{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2042098611411127","article-title":"New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?","volume":"2","author":"French","year":"2011","journal-title":"Therapeutic Advances in Drug Safety"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1017\/S1461145709990836","article-title":"Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine","volume":"13","author":"Gau","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/hir.12251","article-title":"Development of a search filter to identify reports of controlled clinical trials within CINAHL Plus","volume":"36","author":"Glanville","year":"2019","journal-title":"Health Information and Libraries Journal"},{"issue":"17","key":"10.1002\/14651858.CD013136.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.12998\/wjcc.v7.i17.2420","article-title":"Attention deficit hyperactivity disorder and comorbidity: a review of literature","volume":"7","author":"Gnanavel","year":"2019","journal-title":"World Journal of Clinical Cases"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bbr.2015.07.009","article-title":"Attention deficit hyperactivity disorder and developmental coordination disorder: two separate disorders or do they share a common etiology","volume":"292","author":"Goulardins","year":"2015","journal-title":"Behavioural Brain Research"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0048|cit48","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/08830738030180020601","article-title":"Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities","volume":"18","author":"Gucuyener","year":"2003","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0050|cit50","first-page":"217","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"7","key":"10.1002\/14651858.CD013136.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archpsyc.61.7.731","article-title":"ADHD as a risk factor for incident unprovoked seizures and epilepsy in children","volume":"61","author":"Hesdorffer","year":"2004","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0052|cit52","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"3","key":"10.1002\/14651858.CD013136.pub2-BIB0053|cit53","first-page":"223","article-title":"A review of executive function deficits and pharmacological management in children and adolescents","volume":"21","author":"Hosenbocus","year":"2012","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0054|cit54","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization","year":"1992"},{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0972-2327.78042","article-title":"Treating children with attention-deficit\/hyperactivity disorder and comorbid epilepsy","volume":"14","author":"Kattimani","year":"2011","journal-title":"Annals of Indian Academy of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD013136.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0883073808330165","article-title":"Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities","volume":"24","author":"Kaufmann","year":"2009","journal-title":"Journal of Child Neurology"},{"issue":"5","key":"10.1002\/14651858.CD013136.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1008810004694","article-title":"Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results","volume":"7","author":"Landgraf","year":"1998","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0059|cit59","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnsys.2014.00016","article-title":"Cognitive-motor interactions of the basal ganglia in development","volume":"8","author":"Leisman","year":"2014","journal-title":"Frontiers in Systems Neuroscience"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fnhum.2014.00268","article-title":"The co-occurrence of autism and attention deficit hyperactivity disorder in children \u2014 what do we know?","volume":"8","author":"Leitner","year":"2014","journal-title":"Frontiers in Human Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD013136.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jpsychires.2012.03.010","article-title":"The latent structure of attention deficit\/hyperactivity disorder in an adult sample","volume":"46","author":"Marcus","year":"2012","journal-title":"Journal of Psychiatric Research"},{"issue":"10","key":"10.1002\/14651858.CD013136.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00003088-200140100-00004","article-title":"Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder","volume":"40","author":"Markowitz","year":"2001","journal-title":"Clinical Pharmacokinetics"},{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0165025412444077","article-title":"Developmental differences in structure of attention-deficit\/hyperactivity disorder (ADHD) between childhood and adulthood","volume":"36","author":"Martel","year":"2012","journal-title":"International Journal of Behavioral Development"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"2018509","DOI":"10.1155\/2016\/2018509","article-title":"Persons with epilepsy: between social inclusion and marginalisation","volume":"2016","author":"Mlinar","year":"2016","journal-title":"Behavioural Neurology"},{"issue":"9859","key":"10.1002\/14651858.CD013136.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0068|cit68","unstructured":"National Alliance on Mental Illness Attention deficit hyperactivity disorder (ADHD) Available at: www.nami.org\/Learn-More\/Mental-Health-Conditions\/ADHD; 2017"},{"issue":"5","key":"10.1002\/14651858.CD013136.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0070|cit70","unstructured":"NHS Choices Attention deficit hyperactivity disorder (ADHD) \u2014 causes www.nhs.uk\/Conditions\/Attention-deficit-hyperactivity-disorder\/Pages\/Causes.aspx 2016"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0071|cit71","unstructured":"National Institue for Health and Care Excellence Attention deficit hyperactivity disorder: diagnosis and management www.nice.org.uk\/guidance\/ng87 2008"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0072|cit72","unstructured":"National Institute of Mental Health Attention-Deficit\/Hyperactivity Disorder; 2016 Available at: www.nimh.nih.gov\/health\/topics\/attention-deficit-hyperactivity-disorder-adhd#part_145444"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD013136.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1528-1167.2005.00350.x","article-title":"Analysis of genetically complex epilepsies","volume":"46","author":"Ottman","year":"2005","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD013136.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1528-1167.2008.01579.x","article-title":"The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country","volume":"49","author":"Picot","year":"2008","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yebeh.2015.02.019","article-title":"Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies","volume":"46","author":"Radziuk","year":"2015","journal-title":"Epilepsy & Behaviour"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0077|cit77","volume-title":"Rang and Dale's Pharmacology","author":"Rang","year":"2011"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0078|cit78","unstructured":"Review Manager 5 (RevMan) Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"3","key":"10.1002\/14651858.CD013136.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00213-004-1833-7","article-title":"Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder","volume":"175","author":"Rhodes","year":"2004","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD013136.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1017\/S0033291705004599","article-title":"Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder","volume":"35","author":"Rhodes","year":"2005","journal-title":"Psychological Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013136.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1469-7610.2006.01633.x","article-title":"Acute neuropsychological effects of methylphenidate in stimulant drug-na\u00efve boys with ADHD II \u2014 broader executive and non-executive domains","volume":"47","author":"Rhodes","year":"2006","journal-title":"Journal of Child Psychology and Psychiatry, and Allied Disciplines"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1469-7610.2011.02436.x","article-title":"A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder","volume":"53","author":"Rhodes","year":"2012","journal-title":"Journal of Child Psychology and Psychiatry, and Allied Disciplines"},{"issue":"12","key":"10.1002\/14651858.CD013136.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/jcpp.13419","article-title":"Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study","volume":"62","author":"Rosenau","year":"2021","journal-title":"Journal of Child Psychology and Psychiatry, and Allied Disciplines"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1542\/peds.2010-1371","article-title":"A national profile of childhood epilepsy and seizure disorder","volume":"129","author":"Russ","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10803-013-1849-0","article-title":"Prevalence of parent-reported ASD and ADHD in the UK: findings from the Millennium Cohort Study","volume":"44","author":"Russell","year":"2014","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","year":"2003","journal-title":"Current Opinion in Neurology"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0087|cit87","volume-title":"Epilepsy 2009: From Benchside to Bedside - a Practical Guide to Epilepsy","author":"Sander","year":"2009"},{"issue":"6","key":"10.1002\/14651858.CD013136.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00003088-200544060-00002","article-title":"Clinical pharmacokinetics of atomoxetine","volume":"44","author":"Sauer","year":"2005","journal-title":"Clinical Pharmacokinetics"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S2215-0366(17)30167-0","article-title":"ADHD in children and young people: prevalence, care pathways, and service provision","volume":"5","author":"Sayal","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013136.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0091|cit91","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6\/","DOI":"10.1002\/9781119536604.ch15"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0092|cit92","unstructured":"Sheslow D Adams W Wide Range Assessment of Memory and Learning, Second Edition (WRAML2); 2003 Available from: www.pearsonclinical.co.uk\/Education\/Assessments\/memory-assessments\/wraml2\/wide-range-assessment-of-memory-and-learning-wraml2.aspx"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0093|cit93","first-page":"1","article-title":"Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies","volume":"5","author":"Shier","year":"2012","journal-title":"Journal of Central Nervous System Disease"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013136.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1528-1167.2009.02451.x","article-title":"Neuropsychology in epilepsy: children are not small adults","volume":"51","author":"Smith","year":"2010","journal-title":"Epilepsia"},{"issue":"11","key":"10.1002\/14651858.CD013136.pub2-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009885.pub2","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","author":"Storeb\u00f8","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013136.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-7610.2012.02611.x","article-title":"What have we learnt about the causes of ADHD?","volume":"54","author":"Thapar","year":"2013","journal-title":"Journal of Child Psychology and Psychiatry, and Allied Disciplines"},{"issue":"2","key":"10.1002\/14651858.CD013136.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yebeh.2007.08.001","article-title":"Attention-deficit\/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment","volume":"12","author":"Torres","year":"2008","journal-title":"Epilepsy & Behavior"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0098|cit98","first-page":"200","volume-title":"Nelson Textbook of Pediatrics","volume":"1","author":"Urion","year":"2016"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0099|cit99","volume-title":"WAIS-III: administration and scoring manual: Wechsler Adult Intelligence Scale","author":"Wechsler","year":"1997"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0100|cit100","first-page":"287","article-title":"Epilepsy and attention-deficit hyperactivity disorder: links, risks and challenges","volume":"12","author":"Williams","year":"2016","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1002\/14651858.CD013136.pub2-BIB0101|cit101","unstructured":"World Bank country and lending groups datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups 2018"},{"issue":"9","key":"10.1002\/14651858.CD013136.pub2-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013136","article-title":"Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy","author":"Walter","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T14:32:48Z","timestamp":1761229968000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013136.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":102,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013136.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}